The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease‐relevant insults
Abstract
Humanin (HN) is a newly identified neuroprotective peptide that specifically suppresses Alzheimer's disease (AD)‐related neurotoxicity. HN peptide has been detected in the human AD brain as well as in mouse testis and colon by immunoblot and immunohistochemical analyses. By means of yeast two‐hybrid screening, we identified TRIM11 as a novel HN‐interacting protein. TRIM11, which is a member of protein family containing a tripartite motif (TRIM), is composed of a RING finger domain, which is a putative E3 ubiquitin ligase, a B‐box domain, a coiled‐coil domain and a B30.2 domain. Deletion of the B30.2 domain in TRIM11 abolished the interaction with HN, whereas the B30.2 domain alone did not interact with HN. For their interaction, at least the coiled‐coil domain was indispensable together with the B30.2 domain. The intracellular level of glutathione S‐transferase‐fused or EGFP‐fused HN peptides or plain HN was drastically reduced by the coexpression of TRIM11. Disruption of the RING finger domain by deleting the first consensus cysteine or proteasome inhibitor treatment significantly diminished the effect of TRIM11 on the intracellular level of HN. These results suggest that TRIM11 plays a role in the regulation of intracellular HN level through ubiquitin‐mediated protein degradation pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there are no reports relating TRIM22 with AD, TRIM11, another member of this family, was shown to bind to and destabilize humanin, a neuroprotective peptide that suppresses AD-related neurotoxicity.49”
From APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease (2016) · cites this paper as [49]
Citations
Cites
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
The tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 1,151
The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T. R., & Liu, Y. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,036
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Does this have a familiar RING?
Saurin, A. J., Borden, K. L. B., Boddy, M. N., & Freemont, P. S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80017-x · Cited by 635
Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y. A., Kawasumi, M., Kouyama, K., Doyu, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101133498 · Cited by 624
Self-citationUBIQUITIN AND THE CONTROL OF PROTEIN FATE IN THE SECRETORY AND ENDOCYTIC PATHWAYS
Bonifacino, J. S., & Weissman, A. M. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.19 · Cited by 613
Cited by
Sorted by citations
Items 101–115 of 115
Ikeda, K., Inoue, S., & Muramatsu, M. (2005) · Springer eBooks · doi:10.1007/0-387-27421-9_16 · Cited by 4
Papel del péptido mitocondrial humanina como blanco terapéutico en cáncer y neurodegeneración
Asad, A. S., Zuccato, C. F., Candia, A. J. N., Gottardo, M. F., Ayala, M. A. M., Theas, M. S., Seilicovich, A., & Candolfi, M. (2019) · Nova · doi:10.22490/24629448.3630 · Cited by 3
Humanin variants aggregate to produce different fibril morphologies
Morris, D. L., Nyenhuis, S. B., Gruschus, J. M., Nyenhuis, D. A., Puja, R., Hinshaw, J. E., & Tjandra, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110403 · Cited by 2
Trimming away tau in neurodegeneration
Noble, W. J., & Hanger, D. P. (2023) · Science · doi:10.1126/science.adj0256 · Cited by 2
Rybak‐Wolf, A. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7441 · Cited by 1
Effects of Proteasome inhibitors on chondrogenesis and Linear bone growth
Eriksson, E. (2013) · Figshare
Singh, R. (2011) · ResearchSpace (University of KwaZulu-Natal)
Promyelocytic Leukemia (PML) and Its Biological Roles
Karbalaie, K., Vallian, S., Lachinani, L., & Nasr‐Esfahani, M. H. (2016) · Zhinitīk dar hizārah-i sivvum
Trim2 mutant mice as a model for cerebellar ataxia
Balaštík, M. (2003) · doi:10.53846/goediss-1393
Hu, M. (2011) · doi:10.17760/d20002114
Slaninová, J., & Patočka, J. (2006) · Kontakt · doi:10.32725/kont.2006.060
Delgado‐Peraza, F., Nogueras‐Ortiz, C. J., Simonsen, A. H., Knight, D. D., Yao, P. J., Goetzl, E. J., Jensen, C. S., Høgh, P., Gottrup, H., Vestergaard, K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24172219
Regulation of NFATc3 stability by SUMO and E3 ubiquitin-ligases Trim39 and Trim17
Basu-Shrivastava, M. (2020) · theses.fr (ABES) · doi:10.70675/0aa33054zc607z413dz8aedz05ed052d5438 · Cited by 1
Metadata
- Authors
- Niikura, T., Hashimoto, Y., Tajima, H., Ishizaka, M., Yamagishi, Y., Kawasumi, M., Nawa, M., Terashita, K., Aiso, S., & Nishimoto, I.
- Affiliations
- Keio University (JP)
- Corresponding author
- Niikura, Takako
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2003-03
- Volume
- 17
- Issue
- 6
- Pages
- 1150-1158
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2076514957
- Cited by
- 115
- References
- 38
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 6 · 2015: 2 · 2014: 6 · 2013: 4 · 2012: 4
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- TRIM11, humanin, Alzheimer's disease, neuroprotection, protein-protein interaction, B30.2 domain, coiled-coil domain, RING E3 ubiquitin ligase, ubiquitin-mediated proteolysis, neurotoxicity, protein stability
- MeSH terms
- Alzheimer Disease, Animals, Carrier Proteins, Membrane Proteins, Proteins, Yeasts, Immunoblotting, Polymerase Chain Reaction, Neuroprotective Agents, Two-Hybrid System Techniques, Ubiquitin, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
